0%
0%
0%
0%
0%
About CV Sciences, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Joseph D. Dowling
Website
cvsciences.com
Headquarters
San Diego
Employees
44
Founded
2010
ISIN
US1266541028
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the following segments: Consumer Products and Specialty Pharmaceutical. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.
$CVSI CV Sciences, Inc. 30% Upside CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol product
$CVSI Flashing Signs of Potential Bottom?CVSI had a brutal last year, but is fighting for fresh support and just broke the longstanding bear trendline suggesting that a turnaround could be in the cards.
-----------------------------
CV Sciences Inc (OTCMKTS:CVSI)
CV Sciences bills itself as a company that operates two distinct business
CV Sciences, Inc On watchlist for reversal opportunity CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol product
CV Science a good risk reward tradeEntry level $2.50 with stop loss $2.15 = Profit target $4.00
Average Analysts recommendation = buy with a $6.33 price target.
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharma
$CVSI Forming A V Bottom$CVSI has been beaten up along with the rest of the cannabis sector.
Recent price action indicates that the low might be in as the critical $1.55 support level held.
Next major resistance level is $3. Those that want to go Long can buy with a stop below $1.55 and add to the position on a break abo
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
